A differentiated product could come out as a clear winner in the crowded heart health market market consisting of fish oils and garlic supplements. Learn about the benefits of a heart health study done with us in just 12 minutes

2.  In 2010 the value of nutraceutical products with
cardiovascular health as their prime positioning focus
amounted to $6.8 billion across the globe
 The global market for heart health ingredients is projected to
reach $15.2 billion by 2018
 Euromonitor predicts Brazil, Russia, India and China (the
BRIC countries) will emerge as the most dynamic growth
markets for cardiovascular health supplements during the
2010-2015 forecast period

3.  1/5 of the deaths in India are from heart disease. By the year 2020, it will
account for 1/3 of all deaths
 Heart disease and diabetes in India occurs 10 to 15 years earlier than in the
west
 An estimated 45 million patients of coronary artery disease in India
 50.8 million diabetics in India, which is the highest ever reported number from
anywhere in the world (International Diabetes Federation)
 Prevalence of diabetes varies between 6-8% in urban and 2-3% in rural
adults
 Steady increase in hypertension prevalence over the last 50 years, more in
urban than in rural areas
 Hypertension is 25-30% in urban and 10-15% in rural subjects
 About 30 percent of corporate employees are afflicted with
obesity, diabetes, coronary ailments and back problems
 77 per cent of working women remain undiagnosed (Assocham, 2009)

4. High Cardiac risk 56.05 %
High Blood Pressure 25.30 %
Diabetes 15.50 %
High Blood Cholesterol 38.23 %

5.  India's loss in terms of potentially productive years due to
lifestyle diseases is one of the highest in the world, reports a
2009 AC Nielsen study
 Drop in productivity due to heart ailments in the young
workforce will cost the country $237 billion between 2005
and 2015, says theWorld Health Organization
 India Inc tops the global stress league table and works the
longest hours, shows up a GrantThornton Report conducted
in 32 countries last year

6.  4,000 cardiologists and 1,200 cardiac surgeons in India
 Cardiovascular disease (CVD) is the leading cause of death and disability
in India (Annual Report, Indian Council of Medical Research, 2002-03)
 60% of the world's cardio-vascular patients are expected to be
in India by 2016
 The cost for laboratory tests, Stress test, Intravenous Ultrasound
done at state of art medical centers and accredited labs in
India is approximately 60-80 % as that of the U.S
 India has the second largest English-speaking population in
the world and the vast majority of patient notes and source
documents are written in English
 Global quality hospitals and clinical research facilities
 Highly developed IT and data collection capability

7.  State of the Art
Hospitals
 Path breaking
cardiovascular research

8. Cost in USA ($) Cost in India ($) Cost Saving %
VLDL
100 25 75%
LDL
HDL
Triglycerides
Total Cholesterol
Apolipoprotein A1 780 30 96%
Apolipoprotein B 410 30 92%
Lipoprotein a 500 60 88%
Stress test 500 30 94%

9. The Key Opinion Leaders for Cardiac health atVedic are qualified medical professionals, dietitians with
an interest in scientific research which extends beyond the realm of commercial interest.
Dr.
Dharmadhakari
Dr. Chopda Dr. Supe
Qualification DM (Cardiology) DM (Cardiology) MD, DNB (Medicine)
Experience 20Years 23Years 15Years.
CT Exp 05 years
13 Clinical trials
completed as a study
Investigator
More than 10 years. 03 years
Participated in over 10 Phase II to
Phase IV global clinical trials
Additional
interests
Fellowship of European
Society of Cardiology.
Social work: Working for
National Rural Health
Mission. Founder of Nashik
Hridya Mitra Charitable
Trust for serving people
under poverty line
Publication in JAPI on Elapid
Ophitoxemia in 2002. Life
member of IMA, NSPHERE,
RSSDI. Winner of Dr. Vasantrao
Gupte Award in 2006 for social
works.
Facility 50 bedded owned super
specialty hospital with
all modern day facilities.
100 bedded owned super
specialty hospital with all
modern day facilities.
25 bedded owned hospital with
ICCU and operation theatre .

10.  Investigators include MD
Physicians, cardiologists, diabetologists, interventiona
l radiologists who provide specialized care in all areas
of cardiovascular care
o Ably supported by skilled and trained
nursing, paramedical staff, customer support and
administrative services
 Sites:
o World class rehabilitation centers, old age homes
o Centers with facilities for the care of mobile and immobile
volunteers
 Specialized digital Cath lab facility to perform
Intravenous ultrasound

11.  Professional team for systematic and
scientific literature reviews
 Cardiac health claim strategies for
nutraceutical products guided by industry
Key Opinion Leaders
 Robust claims for reduction of Cholesterol,
LDL,VLDL, Lipoprotiens; increase in HDL
levels, Controlling thickness of carotid
artery intima and Media layers

12. Vedic Lifesciences is a full service CRO with special
expertise and broad experience in Natural Products
Research and Regulatory Affairs
India
203, Morya Landmark 1, Off New Link Road,AndheriWest,
Mumbai 400053, INDIA
Tel.: +91 22 42172300 / +91 22 42025719
USA
16 BarcelonaCircle, Redwood Shores, CA. 94065, USA
Tel: 1(650)855-4832
For a Corporate Introduction
bizdev@vediclifesciences.com
www.vediclifesciences.com